{"transactions":[{"id":1686825,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T16:15:41.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":119000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option shall vest and become exercisable on January 1, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":119000,"derivative":{"exercise_price":5.71,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":119000},"source":{"system":"sec-edgar","filing":"0001209191-24-000768","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778843/000120919124000768/doc4.xml","form_type":"4"}},{"id":2065337,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T16:31:37.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":135000,"derivative":{"exercise_price":7.78,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001209191-23-000958","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778843/000120919123000958/doc4.xml","form_type":"4"}},{"id":2359216,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-02T18:32:09.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":117450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":117450,"derivative":{"exercise_price":13.41,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":117450},"source":{"system":"sec-edgar","filing":"0000899243-22-008681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778843/000089924322008681/doc4.xml","form_type":"4"}},{"id":2654318,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-25T17:00:46.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":113298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of this option shall vest and become exercisable on May 28, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":113298,"derivative":{"exercise_price":19,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":113298},"source":{"system":"sec-edgar","filing":"0000899243-21-025984","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778843/000089924321025984/doc4.xml","form_type":"4"}},{"id":2654317,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-25T17:00:46.000Z","date":"2021-04-12","kind":"grant","acquired":true,"shares":387069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 17, 2021, the Issuer completed a one-for-3.5305 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction occurred prior to the Issuer's initial public offering, and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 17, 2021, the Issuer completed a one-for-3.5305 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option shall vest and become exercisable on February 8, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On June 17, 2021, the Issuer completed a one-for-3.5305 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 17, 2021, the Issuer completed a one-for-3.5305 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."}],"balance_after":387069,"derivative":{"exercise_price":6.14,"expiration_date":"2031-04-12","underlying":"Common Stock","underlying_shares":387069},"source":{"system":"sec-edgar","filing":"0000899243-21-025984","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778843/000089924321025984/doc4.xml","form_type":"4"}},{"id":3031995,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-09-14T20:19:08.000Z","date":"2020-09-14","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option are scheduled to vest in equal quarterly installments from January 1, 2019 through December 31, 2022."}],"balance_after":75592,"derivative":{"exercise_price":7.84,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0000899243-20-024982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320024982/doc4.xml","form_type":"4"}},{"id":3031994,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-09-14T20:19:08.000Z","date":"2020-09-14","kind":"exercise","acquired":true,"shares":6350,"price":7.84,"value":49784.0,"ownership":{"direct":true},"balance_after":133438,"source":{"system":"sec-edgar","filing":"0000899243-20-024982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320024982/doc4.xml","form_type":"4"}},{"id":3085435,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-09T20:18:32.000Z","date":"2020-07-08","kind":"exercise","acquired":false,"shares":2951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option are scheduled to vest in equal quarterly installments from January 1, 2019 through December 31, 2022."}],"balance_after":81942,"derivative":{"exercise_price":7.84,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":2951},"source":{"system":"sec-edgar","filing":"0000899243-20-018817","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320018817/doc4.xml","form_type":"4"}},{"id":3085434,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-09T20:18:32.000Z","date":"2020-07-08","kind":"sale","acquired":false,"shares":2951,"price":20,"value":59020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."}],"balance_after":127088,"source":{"system":"sec-edgar","filing":"0000899243-20-018817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320018817/doc4.xml","form_type":"4"}},{"id":3085433,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-09T20:18:32.000Z","date":"2020-07-08","kind":"exercise","acquired":true,"shares":2951,"price":7.84,"value":23135.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."}],"balance_after":130039,"source":{"system":"sec-edgar","filing":"0000899243-20-018817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320018817/doc4.xml","form_type":"4"}},{"id":3094822,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-01T20:39:22.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option are scheduled to vest in equal quarterly installments from January 1, 2019 through December 31, 2022."}],"balance_after":84893,"derivative":{"exercise_price":7.84,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":141},"source":{"system":"sec-edgar","filing":"0000899243-20-018121","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320018121/doc4.xml","form_type":"4"}},{"id":3094821,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-01T20:39:22.000Z","date":"2020-06-30","kind":"sale","acquired":false,"shares":141,"price":20,"value":2820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."}],"balance_after":127088,"source":{"system":"sec-edgar","filing":"0000899243-20-018121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320018121/doc4.xml","form_type":"4"}},{"id":3094820,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-01T20:39:22.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":141,"price":7.84,"value":1105.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."}],"balance_after":127229,"source":{"system":"sec-edgar","filing":"0000899243-20-018121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320018121/doc4.xml","form_type":"4"}},{"id":3128678,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-01T20:15:25.000Z","date":"2020-05-28","kind":"exercise","acquired":false,"shares":2232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option are scheduled to vest in equal quarterly installments from January 1, 2019 through December 31, 2022."}],"balance_after":85034,"derivative":{"exercise_price":7.84,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":2232},"source":{"system":"sec-edgar","filing":"0000899243-20-014719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320014719/doc4.xml","form_type":"4"}},{"id":3128677,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-06-01T20:15:25.000Z","date":"2020-05-28","kind":"sale","acquired":false,"shares":2232,"price":20,"value":44640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."}],"balance_after":127088,"source":{"system":"sec-edgar","filing":"0000899243-20-014719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320014719/doc4.xml","form_type":"4"}},{"id":3128676,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-06-01T20:15:25.000Z","date":"2020-05-28","kind":"exercise","acquired":true,"shares":2232,"price":7.84,"value":17498.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."}],"balance_after":129320,"source":{"system":"sec-edgar","filing":"0000899243-20-014719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320014719/doc4.xml","form_type":"4"}},{"id":3130294,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-29T20:15:26.000Z","date":"2020-05-27","kind":"exercise","acquired":false,"shares":448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option are scheduled to vest in equal quarterly installments from January 1, 2019 through December 31, 2022."}],"balance_after":87266,"derivative":{"exercise_price":7.84,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":448},"source":{"system":"sec-edgar","filing":"0000899243-20-014552","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320014552/doc4.xml","form_type":"4"}},{"id":3130293,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-05-29T20:15:26.000Z","date":"2020-05-27","kind":"sale","acquired":false,"shares":448,"price":20,"value":8960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."}],"balance_after":127088,"source":{"system":"sec-edgar","filing":"0000899243-20-014552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320014552/doc4.xml","form_type":"4"}},{"id":3130292,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-05-29T20:15:26.000Z","date":"2020-05-27","kind":"exercise","acquired":true,"shares":448,"price":7.84,"value":3512.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."}],"balance_after":127536,"source":{"system":"sec-edgar","filing":"0000899243-20-014552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320014552/doc4.xml","form_type":"4"}},{"id":3131683,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-28T20:16:49.000Z","date":"2020-05-26","kind":"exercise","acquired":false,"shares":412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option are scheduled to vest in equal quarterly installments from January 1, 2019 through December 31, 2022."}],"balance_after":87714,"derivative":{"exercise_price":7.84,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":412},"source":{"system":"sec-edgar","filing":"0000899243-20-014416","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320014416/doc4.xml","form_type":"4"}},{"id":3131682,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-05-28T20:16:49.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":412,"price":20,"value":8240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."}],"balance_after":127088,"source":{"system":"sec-edgar","filing":"0000899243-20-014416","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320014416/doc4.xml","form_type":"4"}},{"id":3131681,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-05-28T20:16:49.000Z","date":"2020-05-26","kind":"exercise","acquired":true,"shares":412,"price":7.84,"value":3230.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."}],"balance_after":127500,"source":{"system":"sec-edgar","filing":"0000899243-20-014416","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320014416/doc4.xml","form_type":"4"}},{"id":3258716,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-20T21:23:58.000Z","date":"2020-02-19","kind":"exercise","acquired":false,"shares":6088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option are scheduled to vest in equal quarterly installments from January 1, 2019 through December 31, 2022."}],"balance_after":88126,"derivative":{"exercise_price":7.84,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":6088},"source":{"system":"sec-edgar","filing":"0000899243-20-005299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320005299/doc4.xml","form_type":"4"}},{"id":3258715,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-02-20T21:23:58.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":6088,"price":20,"value":121760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."}],"balance_after":127088,"source":{"system":"sec-edgar","filing":"0000899243-20-005299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320005299/doc4.xml","form_type":"4"}},{"id":3258714,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-02-20T21:23:58.000Z","date":"2020-02-19","kind":"exercise","acquired":true,"shares":6088,"price":7.84,"value":47729.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2019."}],"balance_after":133176,"source":{"system":"sec-edgar","filing":"0000899243-20-005299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320005299/doc4.xml","form_type":"4"}},{"id":3301040,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-27T21:25:10.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":58900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 23, 2020 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2020, subject to continued service."}],"balance_after":58900,"derivative":{"exercise_price":16.87,"expiration_date":"2030-01-22","underlying":"Common Stock","underlying_shares":58900},"source":{"system":"sec-edgar","filing":"0000899243-20-002034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320002034/doc4.xml","form_type":"4"}},{"id":3458963,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":95455,"kind":"person","name":"Wallace Owen B.","position":1,"cik":"0001778843","reported_name":"Wallace Owen B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-18T21:28:52.000Z","date":"2019-07-18","kind":"grant","acquired":true,"shares":44493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on July 18, 2019. The shares underlying the option are scheduled to vest in equal quarterly installments from July 1, 2019 through June 30, 2023."}],"balance_after":44493,"derivative":{"exercise_price":16,"expiration_date":"2029-07-17","underlying":"Common Stock","underlying_shares":44493},"source":{"system":"sec-edgar","filing":"0001104659-19-040973","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000110465919040973/a4.xml","form_type":"4"}}]}